August 17, 2018
TB Alliance Statement on WHO Rapid Communication Regarding MDR-TB Treatment
Forthcoming Recommendations Point to Treatment Changes for Drug-Resistant TB July 13, 2018
TB Alliance Names Angela Vanderploeg as Chief Financial Officer
Vanderploeg Brings Comprehensive Financial Management Experience to Help Guide Pursuit of Life-Saving New Tuberculosis Therapies July 6, 2018
In Memory of Professor Denis Mitchison
Statement from TB Alliance June 5, 2018
Statement on Civil Society Hearing on the UN High Level Meeting on Tuberculosis
PDPs urge commitment to tripling the overall annual investments in TB R&D June 4, 2018
TB Alliance Names Sandeep Juneja as Senior Vice President for Market Access
Juneja Brings Industry Expertise to Initiatives that Accelerate Access to New TB Drug Regimens April 26, 2018
Global MPs Urge Heads of State to Act on Tuberculosis
Parliamentarians from around the world are calling for heads of state to bring the global epidemic of tuberculosis (TB) to an end March 29, 2018
After World TB Day, High Expectations for Action
A message from Mel Spigelman, TB Alliance President and CEO March 6, 2018
Nancy Miller-Rich Joins TB Alliance Board of Directors
Miller-Rich has 35 years of experience in the pharmaceutical industry, including global business development at Merck Pharmaceuticals February 7, 2018
ZeNix Clinical Trial Announced
New trial evaluates whether the efficacy of the BPaL drug regimen can be maintained with reduced toxicity November 17, 2017